RIVERVEST VENTURE PARTNERS
RIVERVEST VENTURE PARTNERS is a Seed, Series A, Series B and Series C+ fund in the US writing $1M–$50M checks into biopharmaceutical, medical-device and life-sciences.
- Stages
- Seed, Series A, Series B, Series C+
- Sectors
- biopharmaceutical, medical-device, life-sciences
- Check size
- $1M–$50M
- Invests in
- US-wide
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 2000
- Assets under management
- $1.6B+
Thesis
RiverVest Venture Partners is a venture capital firm established in September 2000, focusing on life sciences, particularly biopharmaceutical and medical device sectors. Headquartered in St. Louis, MO, with offices in San Diego, CA, and Cleveland, OH, they invest primarily in North America. Their strategy targets early-stage companies (seed, Series A, Series B) and growth equity, emphasizing products addressing significant unmet medical needs with clear regulatory paths and demonstrated clinical potential. They actively participate in founding companies, lead financings, and build investor syndicates. RiverVest manages multiple funds, including the Archer Seed Fund for very early-stage ventures and the 3x5 Special Opportunity Fund for later-stage life science and natural resource investments. The firm has raised over $1.6 billion in AUM across eight funds, with its largest fund, RiverVest Venture Fund V, closing at $275 million in March 2021. Typical deal sizes range from $10 million to $50 million, with specific partners having different 'sweet spots' for investment amounts.
Common questions
Does RIVERVEST VENTURE PARTNERS invest at the Seed stage?
Yes. RIVERVEST VENTURE PARTNERS lists Seed, Series A, Series B and Series C+ among the stages it invests in.
What check size does RIVERVEST VENTURE PARTNERS write?
RIVERVEST VENTURE PARTNERS writes $1M–$50M checks.
Where does RIVERVEST VENTURE PARTNERS invest?
RIVERVEST VENTURE PARTNERS invests in the US.